- Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study
-
Baù M, Moretti A, Bertoni E, Vazzoler V, Luini C, Agosti M, Salvatore
- KMID: 2467892
- Pediatr Gastroenterol Hepatol Nutr.
- 2020 Jan;23(1):35-48.
- doi: 10.5223/pghn.2020.23.1.35
PURPOSE: Gastrointestinal symptoms are often related to antibiotic treatment. Their incidence, risk and protective conditions in children are not well defined and represent the aims of this study. METHODS: We prospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients
-
Pellicelli A, Messina V, Giannelli , Distefano , Palitti VP, Vignally P, Tarquini P, Izzi A, Moretti A, Babudieri , Dell’Isola S, Marignani , Scifo G, Iovinella , Cariti G, Pompili M, Candilo FD, Fontanella L, Ettorre GM, Vennarecci G, Ippolito A, Barbarini
- KMID: 2500540
- Gut Liver.
- 2020 May;14(3):357-367.
- doi: 10.5009/gnl18269
Background/Aims: Patients with genotype 3 hepatitis C virus (G3-HCV) cirrhosis are very difficult to treat compared to patients with other HCV genotypes. The optimal treatment duration and drug regimen associated... -
- CITED
-
- Close
- SHARE
-
- Close
